Evercore ISI raised the firm’s price target on Teladoc (TDOC) to $9 from $8 and keeps an In Line rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc Stock Surges Amid Bullish Options Activity
- Unusually active option classes on open October 3rd
- Teladoc put volume heavy and directionally bearish
- Teladoc call volume above normal and directionally bullish
- Teladoc’s Transition to Insurance-Based Model and Mixed Growth Signals Lead to Hold Rating